M184V/I does not impact the efficacy of abacavir/lamivudine/dolutegravir use as switch therapy in virologically suppressed patients
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2020 |
| Author/s | |
| Publication date | February 17, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |